論文

2020年11月

Unseiin, a Kampo medicine, Reduces the Severity and Manifestations of Skin Toxicities Induced by Cetuximab: A Case Report.

Yonago acta medica
  • Kenkichiro Taira
  • ,
  • Kazunori Fujiwara
  • ,
  • Takahiro Fukuhara
  • ,
  • Tsuyoshi Morisaki
  • ,
  • Satoshi Koyama
  • ,
  • Ryohei Donishi
  • ,
  • Hiromi Takeuchi

63
4
開始ページ
379
終了ページ
384
記述言語
英語
掲載種別
DOI
10.33160/yam.2020.11.020

Cetuximab is an effective drug used to treat patients with recurrent or metastatic head and neck squamous cell carcinoma. Skin toxicities such as paronychia and skin exsiccation are common adverse events caused by cetuximab. Skin toxicities may cause significant physical and psychosocial discomfort. The goal of managing skin toxicities is to minimize the detrimental effects on quality of life and continue the treatment. In one patient, skin toxicities became severe, up to grade 2, during treatment. The pain induced by paronychia and skin exsiccation made daily life difficult. Ten days after starting Unseiin, symptoms and finger findings resolved significantly. The patient could resume daily activities. No adverse effects induced by Unseiin were observed during treatment. Unseiin was effective on paronychia and skin exsiccation in this case and may contribute to successful treatment of skin toxicities induced by cetuximab.

リンク情報
DOI
https://doi.org/10.33160/yam.2020.11.020
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33253347
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683911
ID情報
  • DOI : 10.33160/yam.2020.11.020
  • PubMed ID : 33253347
  • PubMed Central 記事ID : PMC7683911

エクスポート
BibTeX RIS